Identification of Oncostatin M as a STAT5-Dependent Mediator of Bone Marrow Remodeling in KIT D816V-Positive Systemic Mastocytosis

This publication has 52 references indexed in Scilit:

• Expression of Activated STAT5 in Neoplastic Mast Cells in Systemic Mastocytosis
  The American Journal of Pathology, 2009
• Single-Cell STAT5 Signal Transduction Profiling in Normal and Leukemic Stem and Progenitor Cell Populations Reveals Highly Distinct Cytokine Responses
  PLOS ONE, 2009
• Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade
  Blood, 2008
• Stat5 activation enables erythropoiesis in the absence of EpoR and Jak2
  Blood, 2008
• Human mast cells release oncostatin M on contact with activated T cells: Possible biologic relevance
  Journal of Allergy and Clinical Immunology, 2008
• Detection of phospho‐STAT5 in mast cells: a reliable phenotypic marker of systemic mast cell disease that reflects constitutive tyrosine kinase activation
  British Journal of Haematology, 2007
• STAT5 regulates the self-renewal capacity and differentiation of human memory B cells and controls Bcl-6 expression
  Nature Immunology, 2005
• Oncostatin M stimulates proliferation, induces collagen production and inhibits apoptosis of human lung fibroblasts
  British Journal of Pharmacology, 2002
• Distinct Mechanisms of STAT Phosphorylation via the Interferon-α/β Receptor
  Journal of Biological Chemistry, 2000
• Role of STAT5 in Interferon-α Signal Transduction in Ba/F3 Cells
  Cellular Signalling, 1999